Saxenda (liraglutide subcutaneous injection – Novo Nordisk, generic) — Cigna
Weight Loss in an Adult with Overweight or Obesity
Initial criteria
- Patient age ≥ 18 years; AND
- Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND
- Patient meets ONE of the following (a or b):
- a) At baseline, patient had a sBMI ≥ 35 kg/m2; OR
- b) [Not fully visible in this chunk, likely additional BMI criterion per later text]
Approval duration
4 months